Skip to search.
 TSX Up 0.10% TSX Ventures Down 0.25%

Cytori Therapeutics, Inc. (CYTX)

-NasdaqGM
0.99 Up 0.00(0.18%) Apr 24, 4:00PM EDT
Add to Portfolio
Prev Close:0.98
Open:1.03
Bid:0.99 x 1000
Ask:1.02 x 100
1y Target Est:5.67
Beta:4.22
Earnings Date:May 11 - May 15 (Est.)
Day's Range:0.96 - 1.03
52wk Range:0.36 - 2.55
Volume:2,518,187
Avg Vol (3m):5,263,180
Market Cap:106.56M
P/E (ttm):N/A
EPS (ttm):-0.48
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
CYTXUp 0.18%106.56M
ASTM 0.00%N/A
BAXDown 0.52%38.67B
OSIRDown 1.57%561.72M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):14.00
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.27
Quarterly EPS Est (Mar-15) :-0.07
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Cytori Therapeutics, Inc., a biotechnology company, develops cell therapeutics for specific diseases and medical conditions. The company primarily provides Cytori Cell Therapy consisting of a heterogeneous population of specialized cells, includin... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback